HK$8.45
1.52%
Hong Kong, Nov 06, 04:08 pm HKT. Closed.
ISIN
HK1093012172
Symbol
1093
Index

CSPC Pharmaceutical Group Limited Stock price

HK$8.45
-1.55 15.50% 1M
+0.21 2.55% 6M
+0.02 0.24% YTD
+0.90 11.92% 1Y
+1.32 18.51% 3Y
+0.55 6.96% 5Y
+4.28 102.80% 10Y
+7.98 1,682.70% 20Y
Hong Kong, Closing price Fri, Nov 06 2026
-0.13 1.52%
ISIN
HK1093012172
Symbol
1093
Index
Industry

AI Insights on CSPC Pharmaceutical Group Limited Insights AI Insights on CSPC Pharmaceutical Group Limited

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$95.9b
Enterprise Value
HK$74.9b
Net debt
positive
Cash
HK$21.8b
Shares outstanding
11.5b
Valuation
P/E
10.1
P/S | estimate
2.2 | 2.5
EV/Sales | estimate
1.7 | 1.9
EV/FCF | ex SBC
5.5 | -
P/B
2.2
Dividends
DPS
HK$0.33
Yield 1Y | 5Y
3.9% | 3.4%
Growth 1Y | 5Y
37.5% | 14.2%
Payout 1Y | 3Y
82.5% | 61.7%
Increased
1 Year
Financials
Revenue | estimate
HK$44.4b | HK$38.6b
EBITDA
-
EBIT
HK$12.0b
Net Income
HK$9.7b
Free Cash Flow | ex SBC
HK$13.6b | -
Growth
Revenue | estimate
45.4% | 26.4%
EBITDA
-
EBIT
105.9%
Net Income
115.0%
Free Cash Flow
294.5%
Margin
Gross
70.9%
EBITDA
-
EBIT
27.0%
Net
21.9%
Free Cash Flow | ex SBC
30.7% | -
Financial Health
Equity Ratio
71.1%
Return on Equity
11.7%
ROCE
24.6%
ROIC
36.6%
Debt/Equity
0.0
More
EPS
HK$0.9
FCF per Share
HK$1.2
Short interest
-
Employees
20k
Rev per Employee
HK$1.6m

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

22x Buy
79%
4x Hold
14%
2x Sell
7%

Analyst Opinions

28 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
79%
Hold
14%
Sell
7%

CSPC Pharmaceutical Group Limited Events

Upcoming Event
NOV
13
Q3 2026 Earnings Call
in 7 days
View Past Earnings Reaction

Financial data from CSPC Pharmaceutical Group Limited

Jun '26
+/-
%
44,407 44,407
45% 45%
100%
- Direct Costs 12,943 12,943
27% 27%
29%
31,464 31,464
54% 54%
71%
- Selling and Administrative Expenses 11,168 11,168
22% 22%
25%
- Research and Development Expense 8,881 8,881
42% 42%
20%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 12,001 12,001
106% 106%
27%
Net Profit 9,739 9,739
115% 115%
22%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Mr. Zhang
Employees 19,700
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today